1. Home
  2. TVTX vs GBX Comparison

TVTX vs GBX Comparison

Compare TVTX & GBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • GBX
  • Stock Information
  • Founded
  • TVTX 2008
  • GBX 1974
  • Country
  • TVTX United States
  • GBX United States
  • Employees
  • TVTX N/A
  • GBX N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • GBX Railroads
  • Sector
  • TVTX Health Care
  • GBX Industrials
  • Exchange
  • TVTX Nasdaq
  • GBX Nasdaq
  • Market Cap
  • TVTX 1.7B
  • GBX 1.8B
  • IPO Year
  • TVTX N/A
  • GBX N/A
  • Fundamental
  • Price
  • TVTX $15.02
  • GBX $45.04
  • Analyst Decision
  • TVTX Strong Buy
  • GBX Hold
  • Analyst Count
  • TVTX 14
  • GBX 2
  • Target Price
  • TVTX $33.31
  • GBX $57.00
  • AVG Volume (30 Days)
  • TVTX 1.9M
  • GBX 246.9K
  • Earning Date
  • TVTX 05-01-2025
  • GBX 07-07-2025
  • Dividend Yield
  • TVTX N/A
  • GBX 2.84%
  • EPS Growth
  • TVTX N/A
  • GBX 85.75
  • EPS
  • TVTX N/A
  • GBX 6.26
  • Revenue
  • TVTX $273,533,000.00
  • GBX $3,511,200,000.00
  • Revenue This Year
  • TVTX $74.41
  • GBX N/A
  • Revenue Next Year
  • TVTX $48.90
  • GBX N/A
  • P/E Ratio
  • TVTX N/A
  • GBX $7.20
  • Revenue Growth
  • TVTX 75.65
  • GBX N/A
  • 52 Week Low
  • TVTX $6.79
  • GBX $37.77
  • 52 Week High
  • TVTX $25.29
  • GBX $71.06
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 35.45
  • GBX 47.80
  • Support Level
  • TVTX $16.37
  • GBX $43.49
  • Resistance Level
  • TVTX $15.48
  • GBX $45.75
  • Average True Range (ATR)
  • TVTX 1.00
  • GBX 0.92
  • MACD
  • TVTX -0.51
  • GBX 0.01
  • Stochastic Oscillator
  • TVTX 3.83
  • GBX 34.07

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

About GBX Greenbrier Companies Inc. (The)

Greenbrier Companies Inc designs, manufactures, and markets railroad freight car equipment in North America and Europe, marine barges in North America and provides wheel services, railcar refurbishment, and parts, leasing and other services to the railroad. Its segments include Manufacturing, Maintenance Services and Leasing & Management Services. The company generates a majority of its revenue from the manufacturing segment. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks: